Population
32 patients, including 7 with minimal change disease (MCD) and 25 with progressive glomerulopathies (PGPs)
Design
Cohort
Authors
Loading...
Supports interstitial angiotensin signaling in progression; hypothesis-generating and should not yet change practice.
Interstitial expression of angiotensin II and AT1 receptor is increased in patients with progressive glomerulopathies, suggesting a potential role in interstitial fibrosis and disease progression.
Bahiense-Oliveira et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: